» U.S. FDA Issues Action Letter For Sugammadex
Schering-Plough Corporation (NYSE: SGP) announced that the U.S. Food and Drug Administration (FDA) has issued a “not-approvable” letter for sugammadex sodium injection for the reversal of muscle…